Literature DB >> 7495869

The choice between alternative IIIb and IIIc exons of the FGFR-3 gene is not strictly tissue-specific.

E Scotet1, E Houssaint.   

Abstract

An essential feature of fibroblast growth factor receptors (FGFR) is the existence of multiple possibilities for alternative splicing. One of these concerns sequences of the mRNA coding for the C-terminal half of Ig domain 3 which corresponds to a part of the ligand-binding site. Two alternative exons, IIIb and IIIc, encode the C-terminal half of Ig domain 3. We show here that the alternative splicing choice between IIIb and IIIc exons of the FGFR-3 is not strictly tissue-specific: epithelial cells show exclusively IIIb transcripts while fibroblastic cells show a mixture of IIIb and IIIc transcripts. This is in contrast with the strictly exclusive alternative choice between IIIb or IIIc exons of the FGFR-2 gene: epithelial cells make only the IIIb choice while fibroblastic cells make only the IIIc choice.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7495869     DOI: 10.1016/0167-4781(95)00156-b

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  17 in total

Review 1.  Beyond VEGF: inhibition of the fibroblast growth factor pathway and antiangiogenesis.

Authors:  Christopher Lieu; John Heymach; Michael Overman; Hai Tran; Scott Kopetz
Journal:  Clin Cancer Res       Date:  2011-09-27       Impact factor: 12.531

Review 2.  Role of fibroblast growth factors in elicitation of cell responses.

Authors:  C Laestander; W Engström
Journal:  Cell Prolif       Date:  2013-12-20       Impact factor: 6.831

Review 3.  Fibroblast growth factor signalling in osteoarthritis and cartilage repair.

Authors:  Yangli Xie; Allen Zinkle; Lin Chen; Moosa Mohammadi
Journal:  Nat Rev Rheumatol       Date:  2020-08-17       Impact factor: 20.543

4.  Influence of heparin mimetics on assembly of the FGF.FGFR4 signaling complex.

Authors:  Krishna Saxena; Ulrich Schieborr; Oliver Anderka; Elke Duchardt-Ferner; Bettina Elshorst; Santosh Lakshmi Gande; Julia Janzon; Denis Kudlinzki; Sridhar Sreeramulu; Matthias K Dreyer; K Ulrich Wendt; Corentin Herbert; Philippe Duchaussoy; Marc Bianciotto; Pierre-Alexandre Driguez; Gilbert Lassalle; Pierre Savi; Moosa Mohammadi; Françoise Bono; Harald Schwalbe
Journal:  J Biol Chem       Date:  2010-06-14       Impact factor: 5.157

5.  Detection of isoform-specific fibroblast growth factor receptors by whole-mount in situ hybridization in early chick embryos.

Authors:  Junko Nishita; Sho Ohta; Steven B Bleyl; Gary C Schoenwolf
Journal:  Dev Dyn       Date:  2011-04-04       Impact factor: 3.780

6.  The fibroblast growth factor receptor, FGFR3, forms gradients of intact and degraded protein across the growth plate of developing bovine ribs.

Authors:  Sujata G Pandit; Prasanthi Govindraj; Joachim Sasse; Peter J Neame; John R Hassell
Journal:  Biochem J       Date:  2002-01-15       Impact factor: 3.857

7.  Epithelial-specific requirement of FGFR2 signaling during tooth and palate development.

Authors:  Ryoichi Hosokawa; Xuemei Deng; Kazunori Takamori; Xun Xu; Mark Urata; Pablo Bringas; Yang Chai
Journal:  J Exp Zool B Mol Dev Evol       Date:  2009-06-15       Impact factor: 2.656

8.  FGF2 posttranscriptionally down-regulates expression of SDF1 in bone marrow stromal cells through FGFR1 IIIc.

Authors:  Takayuki Nakayama; Noriko Mutsuga; Giovanna Tosato
Journal:  Blood       Date:  2006-10-31       Impact factor: 22.113

9.  Fibroblast growth factor receptor 3-IIIc mediates colorectal cancer growth and migration.

Authors:  G Sonvilla; S Allerstorfer; C Heinzle; S Stättner; J Karner; M Klimpfinger; F Wrba; H Fischer; C Gauglhofer; S Spiegl-Kreinecker; B Grasl-Kraupp; K Holzmann; M Grusch; W Berger; B Marian
Journal:  Br J Cancer       Date:  2010-03-16       Impact factor: 7.640

10.  Connexin hemichannel composition determines the FGF-1-induced membrane permeability and free [Ca2+]i responses.

Authors:  Kurt A Schalper; Nicolás Palacios-Prado; Mauricio A Retamal; Kenji F Shoji; Agustín D Martínez; Juan C Sáez
Journal:  Mol Biol Cell       Date:  2008-05-21       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.